The article reports on the genomics research conducted by the Wellcome Trust Case Control Consortium (WTCCC) in Great Britain. The study aimed to identify genetic risk factors for common diseases. WTCCC researchers scanned deoxyribonucleic acid (DNA) from patients and controls for the frequency with which they contained each of the 500,000 genetic markers or single nucleotide polymorphisms from the human genome.